• Recombinant Human EGF: Mechanism and Workflow

  2026-08-20

  Epidermal Growth Factor is an EGFR-binding ligand that regulates cell proliferation and differentiation. Recombinant human EGF P1008 combines a defined His-tagged bacterial expression product with product-reported purity, endotoxin, storage, and BALB/c 3T3 activity benchmarks.

• BV6 IAP Antagonist: Assays and Workflows

  2026-08-20

  BV6 is a Smac mimetic for dissecting IAP-dependent survival, with practical applications in cancer-cell apoptosis, radiotherapy response, immune-cell cytotoxicity, and endometriosis treatment research. This workflow-centered guide connects dose selection and mechanism-resolved readouts with a 2025 study showing why reduced RIPK3 abundance should not be mistaken for blocked necroptosis.

• Perphenazine Workflows for D2 and Host-Directed Research

  2026-08-19

  Perphenazine is a dopamine D2 receptor antagonist that supports both receptor-signaling studies and phenothiazine-based host-defense assays. This workflow connects dose-controlled neuropharmacology experiments with ROS, autophagy, mitochondrial, and intracellular-bacteria readouts while emphasizing controls for cytotoxicity and receptor promiscuity.

• NSC-23766: From Rac1 Mechanism to Translation

  2026-08-19

  NSC-23766 is a Rac GTPase inhibitor that helps translational researchers connect Rac1-GEF biology with endothelial barrier disruption, apoptosis, cell-cycle phenotypes, and immune-cell cytoskeletal behavior. This thought-leadership perspective explains how to deploy NSC23766 trihydrochloride as a mechanistic probe while avoiding overinterpretation of context-dependent results.

• Metformin Hydrochloride in Immunometabolism

  2026-08-18

  Metformin Hydrochloride extends beyond conventional glucose studies as a controllable metabolic intervention for standardized whole-blood immune assays. This guide shows how to connect AMPK-linked metabolic changes with cytokine readouts, while controlling solubility, donor variability, vehicle effects, and assay timing.

• Podophyllotoxin: Mechanism, Evidence, and Workflows

  2026-08-18

  Podophyllotoxin is a microtubule-directed research compound used to investigate mitotic disruption, cell cycle arrest, and apoptosis. This guide separates evidence for native Podophyllotoxin from findings for the structurally modified derivative 5p and defines practical handling limits for N1790.

• QNZ (EVP4593): Reliable NF-κB Assays

  2026-08-17

  This scenario-based guide shows how QNZ (EVP4593), SKU A4217, can be integrated into NF-κB, viability, proliferation, and cytotoxicity workflows without confusing pathway inhibition with nonspecific cell injury. It covers assay design, solvent control, stock preparation, data interpretation, and practical vendor selection.

• Necrostatin-1: RIP1 Kinase Inhibitor Guide

  2026-08-17

  Necrostatin-1 is a selective RIP1 kinase inhibitor used to interrogate necroptosis, inflammation, and tissue injury. Product data report blockade of TNF-α-induced necroptosis, while peer-reviewed work connects RIP1–RIP3 signaling with inflammatory pulmonary dysfunction.

• Rocket-Like Nanomedicine Restores PDAC Stroma

  2026-08-16

  Fu and colleagues developed an acid-responsive, sequential-release nanomedicine that combines stromal remodeling with gemcitabine delivery in pancreatic ductal adenocarcinoma. By releasing halofuginone and IPR-803 before gemcitabine-loaded mesoporous silica nanoparticles, the platform restored aspects of stromal homeostasis and produced marked tumor regression in a PDAC mouse model.

• Maraviroc: CCR5 Biology from HIV to Stroke

  2026-08-15

  Maraviroc (UK-427857) is a selective CCR5 antagonist for dissecting HIV-1 entry inhibition and chemokine signaling. This article presents a compartment- and time-aware framework for connecting HIV tropism studies with emerging neuroinflammation modulation research without overstating translational evidence.

• Ibrutinib and the Next Era of BTK Translation

  2026-08-14

  Ibrutinib and PCI-32765 offer a powerful framework for interrogating BTK-dependent biology, from B-cell receptor signaling inhibition and chronic lymphocytic leukemia research to autoimmune disease models. This thought-leadership article connects covalent target engagement with experimental design, translational stratification, and the responsible interpretation of cross-domain evidence.

• One-step TUNEL FITC Apoptosis Detection Kit Workflow

  2026-08-14

  Build a reproducible DNA fragmentation assay for tissue sections, adherent cells, suspension cells, and flow cytometry. This workflow connects TUNEL-positive cell mapping with the omics-anchored reproductive toxicity findings reported for gestational polystyrene nano-plastics exposure.

• Trelagliptin succinate in Bone and Diabetes Research

  2026-08-13

  Trelagliptin succinate, also known as SYR-472 succinate, supports integrated studies of DPP-4 biology, glucose regulation, and osteoblast differentiation. This practical guide connects assay setup, AMPK–RUNX2 validation, metabolic models, and troubleshooting for more reproducible diabetes mellitus research.

• 3X (DYKDDDDK) Peptide: Uses & Workflow

  2026-08-13

  The 3X (DYKDDDDK) Peptide is a compact, hydrophilic FLAG epitope reagent for antibody-based detection and affinity workflows. Its reported solubility and storage conditions support routine handling, while metal sensitivity and sequence verification remain important controls.

• Methyl-β-cyclodextrin: Membrane Workflow Guide

  2026-08-12

  Methyl-β-cyclodextrin is a research reagent for controlled membrane cholesterol extraction and related studies of lipid organization, membrane fluidity, and cholesterol-dependent signaling. It should be optimized for each cell and assay system, used promptly after solution preparation, and not used for diagnostic, therapeutic, or medical applications.

7616 records 2/508 page Previous Next 12345 下5页 Last page